Effect of a passive endocardial electrode on defibrillation efficacy of a nonthoracotomy lead system

Journal of the American College of Cardiology

Volumn 29, Issue 4, 1997, Pages 825-830

  Fotuhi, Parwis C ^a   Kenknight, Bruce H ^b   Melnick, Sharon B ^c   Smith, William M ^c   Baumann, Gert F ^a   Ideker, Raymond E ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b ELI LILLY AND COMPANY   (United States)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DEFIBRILLATION; DEFIBRILLATOR; DOG; ELECTRODE; HEART PACING; HEART VENTRICLE FIBRILLATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; DEFIBRILLATORS, IMPLANTABLE; DOGS; ELECTRODES, IMPLANTED;

EID: 0030887221     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00573-6     Document Type: Article

References (17)

1. Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implantable defibrillator in human beings. N Engl J Med. 303:1980;322-324.
2. Coumel P. Historical milestones of implanted defibrillation. PACE. 15:1992;598-603.
3. Nisam S, Mower MM, Thomas A, Hauser R. Patient survival comparison in three generations of automatic implantable cardioverter defibrillators review of 12 years, 25,000 patients . PACE. 16:1993;174-178.
4. Epstein AE, Kay GN. Implantation of cardioverter-defibrillators in the electrophysiology laboratory. Singer I. Implantable Cardioverter Defibrillator. 1994;357-364 Futura, Armonk (NY).
5. Bardy GH, Hofer B, Johnson G, et al. Implantable transvenous cardioverter-defibrillators. Circulation. 87:1993;1152-1168.
6. Callihan RL, Idriss SF, Dahl RW, Wolf PD, Smith WM, Ideker RE. Comparison of defibrillation probability of success curves for an endocardial lead configuration with and without an inactive epicardial patch. J Am Coll Cardiol. 25:1995;1373-1379.
7. Fotuhi PC, Ideker RE, Idriss SF, Callihan RL, Walker RG, Alt EU. Influence of epicardial patches on defibrillation threshold with nonthoracotomy lead configurations. Circulation. 92:1995;3082-3088.
8. Roelke M, O'Nunain SS, Osswald S, Garan H, Harthorne O, Ruskin UN. Subclavian crush syndrome complicating transvenous cardioverter defibrillator systems. PACE 18:973-9.
9. Magney JE, Flynn DM, Parson JA, et al. Anatomical mechanisms explaining damage to pacemaker leads, and failure of central venous catheter adjacent to the sternoclavicular joint. PACE. 16:1993;445-457.
10. Wilkoff BL, Smith HJ, Goode LB. Transvenous extraction of non-thoracotomy defibrillation leads an emerging technical challenge [abstract] . Eur J Cardiac Pacing Electrophysiol. 4 Suppl:1994;132.
11. Epstein AE, Anderson PG, Shepard RB, Plumb VJ, Dailey SM, Kay NG. Gross and microscopic changes associated with nonthoracotomy implantable defibrillator leads [abstract]. Circulation. 90 Suppl I:1994;I-653.
12. Babbs CF. Effect of pentobarbital anesthesia on ventricular defibrillation threshold in dogs. Am Heart J. 95:1978;331-337.
13. Gill RM, Sweeney RJ, Reid PR. The defibrillation threshold a comparison of anesthetics and measurement methods . PACE. 16:1993;708-714.
14. Bourland JD, Tacker WA Jr, Geddes LA. Strength-duration curves for trapezoidal waveforms of various tilts for transchest defibrillation in animals. Med Instrum. 12:1978;38-41.
15. Marchlinski FE. Nonthoracotomy defibrillator lead systems a welcomed addition but still a lot to learn . Circulation. 87:1993;1410-1411.
16. Usui M, Walcott GP, KenKnight BH, et al. Influence of malpositioned transvenous leads on defibrillation efficacy with and without a subcutaneous array electrode. PACE. 18:1995;2008-2016.
17. Brooks R, Garan H, McGovern BA, Ruskin JN. Implantation of transvenous nonthoracotomy cardioverter-defibrillator systems in patients with permanent endocardial pacemakers. Am Heart J. 129:1995;45-53.